Article
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study.
Circulation - 28 Nov 2006
Sacher Frédéric, Probst Vincent, Iesaka Yoshito, Jacon Peggy, Laborderie Julien, Mizon-Gérard Frédérique, Mabo Philippe, Reuter Sylvain, Lamaison Dominique, Takahashi Yoshihide, O'Neill Mark D, Garrigue Stéphane, Pierre Bertrand, Jaïs Pierre, Pasquié Jean-Luc, Hocini Mélèze, Salvador-Mazenq Michèle, Nogami Akihiko, Amiel Alain, Defaye Pascal, Bordachar Pierre, Boveda Serge, Maury Philippe, Klug Didier, Babuty Dominique, Haïssaguerre Michel, Mansourati Jacques, Clémenty Jacques, Le Marec Hervé
Abstract excerpt
BACKGROUND: Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudden cardiac death (SCD) by ventricular fibrillation. At present, an implantable cardioverter-defibrillator (ICD) is the recommended therapy in high-risk patients. This multicenter study reports the outcome of a large series of patients implanted with an ICD for Brugada syndrome. METHODS AND RESULTS: All patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.